Plain-English translation of NCT06851247 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new treatment approach for advanced nasopharyngeal cancer (a type of throat cancer). The treatment combines three components: two newer medications called and , traditional chemotherapy drugs, and radiation therapy. After the initial intensive treatment, participants continue taking as a maintenance therapy to help keep the cancer from returning.
Nasopharyngeal cancer that is caught at an advanced stage is difficult to treat, and current treatments don't work well enough for all patients. Researchers believe that combining this medication with traditional chemotherapy and radiation may improve survival rates and give patients better long-term outcomes.
You likely qualify if…
You likely don't qualify if…
You would receive several rounds of chemotherapy over a few weeks, combined with daily radiation therapy to your throat area. After this intensive initial phase, you would continue taking the maintenance medication for an extended period while your doctors monitor you closely. Throughout the trial, you would have regular blood tests, scans, and clinic visits to track how well the treatment is working and watch for any side effects.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
China